British Journal of Haematology · 1999 · 103 citations · 16 references
ImmunologyPathologyDermatologyPlasma CellsAngiogenesisHematologyLymphatic SystemVegf LevelsMature Plasma CellsHealth SciencesAutoimmune DiseaseHistopathologyAutoimmunityVascular BiologyNeovascularizationSclerodermaVascular Endothelial Growth FactorCell BiologyTumor MicroenvironmentLymph NodesPlasma Cell TypeEndothelial DysfunctionGeneral PathologyLymphatic DiseaseMedicine
To evaluate the possible involvement of vascular endothelial growth factor (VEGF) in the pathogenesis of Castleman's disease, we studied VEGF levels in sera and supernatants of cultured lymph nodes from two patients with the plasma cell type of Castleman's disease, and analysed the expression of VEGF immunohistochemically in the lymph nodes. Clinically, one patient was classified as the localized type and the other as the multicentric type. Histologically, mature plasma cells and hyalinized vessels were prominent in the interfollicular region. The VEGF levels of the sera and the supernatants of cultured lymph nodes of both patients were higher than those of normal controls. VEGF was strongly expressed in plasma cells in the interfollicular region of the lymph nodes of both patients, but rarely in normal lymph nodes. Our results suggest that VEGF may be involved in the marked vascular proliferation in the interfollicular region of the lymph nodes of the plasma cell type of Castleman's disease.
16
Interleukin 6 Induces the Expression of Vascular Endothelial Growth Factor
Tzafra Cohen, Dorit Nahari, Lea Weiss Cerem et al. · Journal of Biological Chemistry · 1996 · 1K citations · Full text
Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease
Kazuyuki Yoshizaki, Tadashi Matsuda, Naoki Nishimoto et al. · Blood · 1989 · 899 citations